Active Ingredient History
Gold trichloride is used as a catalyst in synthesis of new compounds. It was shown that gold trichloride was not the marker of contact allergy and could not be recommended in patch testing. NCATS
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Neoplasm Metastasis (approved 1950)
Amyotrophic Lateral Sclerosis (Phase 2/Phase 3)
Arthritis, Rheumatoid (Phase 3)
Healthy Volunteers (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 2/Phase 3)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Neuritis (Phase 2)
Optic Nerve Diseases (Phase 2)
Parkinson Disease (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue